MET — MetLife, Inc.

MetLife Q4 2025 Earnings Call Summary

1. Key Financial Results and Metrics

• Q4 Adjusted Earnings: $1.6 billion or $2.49 per share; $2.58 per share excluding notable items, a 24% increase from $2.08 per share year-over-year.
• Full Year Adjusted Earnings: $6 billion or $8.89 per share, up approximately 10%.
• Adjusted Return on Equity (ROE): 16%, within the target range of 15%-17%.
• Direct Expense Ratio: Improved to 11.7%, ahead of the five-year target of 11.3%.
• Free Cash Flow: $4.9 billion generated in 2025, contributing to a five-year target of $25 billion.
• Net Income: Approximately $800 million for Q4 and $3.2 billion for the full year.

2. Strategic Updates and Business Highlights

• New Frontier Strategy: Focused on growth, capital deployment, and operational efficiency. Key initiatives include the acquisition of PineBridge Investments and the establishment of MetLife Investment Management (MIM).
• Group Benefits: Added approximately $100 million in new adjusted premiums, with voluntary products growing 10% year-over-year.
• Retirement Solutions: Achieved record pension risk transfer sales of over $14 billion, the highest annual total for MetLife.
• International Growth: Asia sales increased by 18% and Latin America by 12% in constant currency.
• Capital Management: Returned $4.4 billion to shareholders via stock repurchases and dividends while funding acquisitions.

3. Forward Guidance and Outlook

• 2026 Expectations:
  • Anticipate double-digit adjusted EPS growth.
  • Adjusted ROE expected to remain in the 15%-17% range.
  • Free cash flow ratio target maintained at 65%-75%.
  • Group Benefits adjusted earnings growth projected at 7%-9%.
  • Retirement Solutions adjusted earnings expected between $1.6 billion and $1.8 billion.
  • MIM adjusted earnings forecasted between $240 million and $280 million, with revenue growth of approximately 30%.

4. Bad News, Challenges, or Points of Concern

• Disability Experience: Weaker than expected results in Q4 due to higher average severity and incidents, although overall trends for the year remained in line with expectations.
• Variable Investment Income: Fell short of the 2025 target of $1.7 billion, totaling $1.5 billion for the year, primarily due to lower returns from real estate and other funds.
• Surrender Activity: Increased in Q4, particularly in Japan, attributed to currency fluctuations; however, it is expected to stabilize in 2026.
• Expense Ratios: The acquisition of PineBridge is expected to increase the direct expense ratio by 50 basis points in 2026.

5. Notable Q&A Insights

• Group Benefits Pricing: Management noted robust results in persistency and renewals, particularly in dental, with positive sales growth anticipated.
• Japan Market Volatility: Management acknowledged macroeconomic volatility affecting sales and persistency but expressed confidence in their product portfolio and distribution strength.
• Impact of AI on Employment: Management is monitoring employment trends related to AI but remains optimistic about growth opportunities in group benefits.
• Reinsurance Strategy: MetLife is leveraging reinsurance to enhance capital flexibility and support liability growth, particularly in the retirement market.

Overall, MetLife demonstrated strong financial performance in Q4 2025, supported by strategic initiatives and a focus on growth, despite facing some challenges in specific segments and macroeconomic conditions. The company remains optimistic about its future outlook and commitment to delivering shareholder value.